A Phase II Single-Arm Study to Evaluate the Feasibility of Preoperative Rehabilitation and Nutrition Intervention in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer - RENUAL trial

Keio University0 sites33 target enrollmentSeptember 24, 2021

Overview

No summary available.

Registry

who.int

Start Date

September 24, 2021

End Date

September 30, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\. Infectious disease requiring systemic treatment. (Because rehabilitation is difficult) 2\. Patient has a fever of 38 degrees Celsius or higher. (Due to difficulty in rehabilitation) Patient has poorly controlled diabetes mellitus (HbA1c of 6\.5% or higher is the standard). (Due to difficulty in nutritional intervention) 4\. Complicated psychosis or psychiatric symptoms, which will make it difficult to participate in the study. (Due to difficulty in rehabilitation) 5\. Patient has poorly controlled hypertension. (Due to difficulty in rehabilitation) 6\. Patient has unstable angina (angina pectoris with onset or worsening within the last 3 weeks) or myocardial infarction within the last 6 months. (Due to difficulty in rehabilitation) 7\. Patient has interstitial pneumonia, pulmonary fibrosis, severe emphysema, or heart failure. (Due to difficulty in rehabilitation) 8\. Patient has a history of cerebrovascular disease (cerebral infarction, intracerebral hemorrhage, transient ischemic attack, etc.) that occurred within 6 months. (Due to difficulty in rehabilitation) 9\. Other patients who are deemed unsuitable for enrollment in this clinical trial by the physician in charge.